Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Prevent Use of Unnecessary Psychotropic Medications as Chemical Restraints

Brewster, Washington Survey Completed on 07-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents were free from chemical restraints, specifically regarding the administration of unnecessary psychotropic medications. Staff C, an RN, discovered a clear liquid in an unmarked medication cup in the medication cart, which Staff D, another RN, identified as lorazepam intended for a resident other than those prescribed. Staff D admitted to giving this controlled medication to two residents, not prescribed the medication, in response to their nighttime wandering and behaviors. Documentation and interviews confirmed that this practice occurred on several occasions. Resident 1, who had diagnoses of Alzheimer's disease and dementia with severe mood disturbance, exhibited unusual sleep patterns and difficulty getting out of bed following the suspected administration of lorazepam. Nursing notes indicated that Resident 1 was verbally aggressive and exit-seeking during the night, followed by an atypical period of extended sleep and lethargy the next day. Observation later showed the resident to be cognitively impaired but active and interactive, which contrasted with the documented behavior after the suspected medication administration. For Resident 3, records showed cognitive impairment and discharge from the facility, but there was no sleep chart or supporting evidence of side effects from the alleged administration of lorazepam. The facility's investigation found an opened bottle of lorazepam, prescribed for another resident, that had been tampered with and removed from use. The administrator acknowledged that the sleep and activity changes in Resident 1 were not typical and likely supported the occurrence of chemical restraint.

An unhandled error has occurred. Reload 🗙